November 7, 2022 Intelligent Bio Solutions Inc. (INBS) Announces UK-Wide Glass Manufacturer to Roll Out Non-Invasive Drug Screening System Across UK Operations November 3, 2022 Intelligent Bio Solutions Inc. Announces Airline Adopts Fingerprint Drug Screening System for In-house Testing November 2, 2022 Intelligent Bio Solutions Inc. to Present First Quarter 2023 Financial Results and Recent Corporate Update on November 9 October 31, 2022 Intelligent Bio Solutions Inc. Announces Leading U.K. Container Haulier Switching to Fingerprint Drug Screening System for In-house Testing October 26, 2022 GBS Inc. Initiates Company Name Change to Intelligent Bio Solutions Inc. (IBSS) and Announces Key Executive Appointments October 4, 2022 GBS Inc. Acquires Intelligent Fingerprinting Limited and its Proprietary Drugs of Abuse Screening Technology August 31, 2022 GBS Inc. Reports Fourth Quarter and Full Year ended June 30, 2022 Preliminary Financial Results and Recent Business Highlights August 29, 2022 GBS Inc. to Present Fourth Quarter and Full Year 2022 Financial Results and Recent Corporate Update on August 31 July 13, 2022 GBS Inc. Announces Key Milestone in Prospective Study Comparing Glucose in Oral Fluids and Blood June 23, 2022 GBS Inc. to Initiate Manufacturing on the University of Newcastle Australia Campus
November 7, 2022 Intelligent Bio Solutions Inc. (INBS) Announces UK-Wide Glass Manufacturer to Roll Out Non-Invasive Drug Screening System Across UK Operations
November 3, 2022 Intelligent Bio Solutions Inc. Announces Airline Adopts Fingerprint Drug Screening System for In-house Testing
November 2, 2022 Intelligent Bio Solutions Inc. to Present First Quarter 2023 Financial Results and Recent Corporate Update on November 9
October 31, 2022 Intelligent Bio Solutions Inc. Announces Leading U.K. Container Haulier Switching to Fingerprint Drug Screening System for In-house Testing
October 26, 2022 GBS Inc. Initiates Company Name Change to Intelligent Bio Solutions Inc. (IBSS) and Announces Key Executive Appointments
October 4, 2022 GBS Inc. Acquires Intelligent Fingerprinting Limited and its Proprietary Drugs of Abuse Screening Technology
August 31, 2022 GBS Inc. Reports Fourth Quarter and Full Year ended June 30, 2022 Preliminary Financial Results and Recent Business Highlights
August 29, 2022 GBS Inc. to Present Fourth Quarter and Full Year 2022 Financial Results and Recent Corporate Update on August 31
July 13, 2022 GBS Inc. Announces Key Milestone in Prospective Study Comparing Glucose in Oral Fluids and Blood
